(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SGD PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SGD PHARMA

ST13

US500000097232177

Class

21

Filing

97232177

Registration

7022542

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

08/14/2026

Trademark type

Combined

Nice classes

21

Filing date

01/21/2022

Registration date

04/11/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/11/2023

Last transaction

08/14/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

2017-12-00

First use in commerce

2017-12-00

Drawing code

3

Owner type

99

Owner location

Puteaux, FR

Examiner

MAHONEY, PAULA M

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized, stacked blue wording "SGD" and "PHARMA" within a circle that has a blue border. The use of white in the drawing represents background and transparent areas and is not claimed as a feature of the mark.

Holders and representatives

Holders

SGD S.A.

Representatives

Mary Margaret L. O'Donnell Blue Filament Law PLLC

Technical classification

Nice Classes

Class 21

Vienna Codes

No Vienna codes available.

Goods and services

Class 21

glass containers sold to manufacturers and packagersglass bottles and glass containers sold empty for use with pharmaceutical and cosmetics productsfragrancessupplements

Publications

History of USPTO decisions and trademark events.

23 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/13/2026

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

08/13/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/13/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/13/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/11/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

04/11/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/24/2023

PUBO

PUBLISHED FOR OPPOSITION

01/24/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/04/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/15/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/23/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/23/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/23/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/26/2022

GNRT

NON-FINAL ACTION E-MAILED

05/26/2022

CNRT

NON-FINAL ACTION WRITTEN

05/26/2022

DOCK

ASSIGNED TO EXAMINER

05/09/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/14/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/14/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/14/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

01/27/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/26/2022

NWAP

NEW APPLICATION ENTERED

01/25/2022

Continuous trademark protection

Get notified about every new filing that threatens SGD PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.